Melanoma treatment is entering a new era with personalized vaccines, which train the immune system to target unique mutations in an individual’s tumor. Used after surgery to prevent recurrence, these therapies are designed for high-risk patients. By harnessing specific neoantigens, this approach offers a tailored defense, potentially improving survival outcomes where standard options fall short.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends